Article
Functional advantage of educated KIR2DL1(+) natural killer cells for anti-HIV-1 antibody-dependent activation.
Clinical and experimental immunology - 1 Apr 2016
Gooneratne S L, Center R J, Kent S J, Parsons M S
Abstract excerpt
Evidence from the RV144 HIV-1 vaccine trial implicates anti-HIV-1 antibody-dependent cellular cytotoxicity (ADCC) in vaccine-conferred protection from infection. Among effector cells that mediate ADCC are natural killer (NK) cells. The ability of NK cells to be activated in an antibody-dependent manner is reliant upon several factors. In general, NK cell-mediated antibody-dependent activation is most robust in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
